Skip to main content
. 2019 Jul 25;15(11):2738–2753. doi: 10.1080/21645515.2019.1600987

Table 1.

Demographic and clinical characteristics.a

          Beforeb
After 2ndc
After 3rdd
Samples Age
(years)
Gender Blood group HLA HBcAb
(S/CO)
HBsAg
(IU/ml)
HBsAb
(mIU/ml)
HBsAb
(mIU/ml)
HBsAb
(mIU/ml)
1 22 Male B type DRB1*140601
DRB1*150201
DQB1*030101
DQB1*060101
DPB1*040201
DPB1*090101
0 0 0 0.5 75.3
2 22 Male A type DRB1*1101
DRB1*040501
DQB1*030101
DQB1*040101
DPB1*020102
DPB1*0501
0 0 0 9.6 391.3
3 24 Male B type DRB1*090102
DRB1*150201
DQB1*030302
DQB1*060101
DPB1*0501
DPB1*090101
0 0 0 0.7 431.1
4 24 Male O type DRB1*080302
DRB1*090102
DQB1*030302
DQB1*060101
DPB1*020102
DPB1*0501
0 0 0 11.2 632.6
5 25 Male O type DRB1*040301
DRB1*100101
DQB1*030302
DQB1*050101
DPB1*020102
DPB1*
0 0 0 3.4 619.3

a All five participants were Asian, had no HB immunization history, were in overall good health, and did not taking any regular medication during the study.

b Before HB vaccination.

c After the second HB vaccination.

d After the third HB vaccination.